Brooke E. Howitt

Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

Brooke E. Howitt, Sachet A. Shukla, Lynette M. Sholl et al. · JAMA Oncology · 2015 · 685 citations · Full text

Medicine, Immunology, Oncology +17

Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer

Kyle C. Strickland, Brooke E. Howitt, Sachet A. Shukla et al. · Oncotarget · 2016 · 621 citations · Full text

Life Sciences, Immunology, Oncology +17

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer

Liya Ding, Hye‐Jung Kim, Qiwei Wang et al. · Cell Reports · 2018 · 571 citations · Full text

Medicine, Oncology, Pharmacology +17

Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology

Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Rebecca C. Arend et al. · Journal of the National Comprehensive Cancer Network · 2023 · 545 citations

Medicine, Gynecology, Oncology +14

NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024

Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Rebecca C. Arend et al. · Journal of the National Comprehensive Cancer Network · 2023 · 354 citations · Full text

Medicine, Oncology, Pathology +17